🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07014553
Active, not recruiting Not applicable

Effect of Web-based Nursing Navigator Programme on Breast Cancer Screening Behaviors in Women at High Risk of Breast Cancer

NCT07014553 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-02-01
Last updated
2026-05-19

Condition(s) studied

Breast Cancer Risk

Investigational drug(s) / intervention(s)

web based nursing navigator programme

web based nursing navigator programme: health education guidance surveillance case management

Study summary

The aim of this project is to determine the effect of the Web-Based Nurse Navigation Program on breast cancer screening behaviors (mammography, BSE, CBE) in women at high risk of breast cancer. The program to be developed within the scope of the project is named as "Web-Based Nurse Navigation Program (WeT-HNP)", which reflects the web-based and navigation concepts.

Eligibility

Sex
FEMALE
Min age
30 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Being 30-70 years old, * Not having been diagnosed with breast cancer, * Not having been included in a breast health program before, * Not having had a mammogram in the last year, * Being at high risk of breast cancer according to the Tyrer-Cuzick Model, * Having a phone, computer or laptop with internet access, * Not having a health problem that prevents vision or hearing, * Being willing to participate in the study. Exclusion Criteria: * Not being able to read or write, * Having a history of breast cancer, * Not being at high risk of breast cancer, * Being pregnant or postpartum, * Not agreeing to participate in the study.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Cancer early diagnosis screening and education center Istanbul Büyükçekmece
Family health center Istanbul Büyükçekmece

More Istanbul University - Cerrahpasa trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07014553 on ClinicalTrials.gov ↗ ← All trials in Turkey